|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Collaborative Group on Hormonal Factors in
Breast Cancer: Familial breast cancer: Collaborative reanalysis of
individual data from 52 epidemiological studies including 58,209
women with breast cancer and 101,986 women without the disease.
Lancet. 358:1389–1399. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lalloo F and Evans DG: Familial breast
cancer. Clin Genet. 82:105–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hynes NE and MacDonald G: ErbB receptors
and signaling pathways in cancer. Curr Opin Cell Biol. 21:177–184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gullick WJ: c-erbB-4/HER4: Friend or foe?
J Pathol. 200:279–281. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCubrey JA, Abrams SL, Fitzgerald TL,
Cocco L, Martelli M, Montalto G, Cervello M, Scalisi A, Candido S,
Libra M and Steelman LS: Roles of signaling pathways in drug
resistance, cancer initiating cells and cancer progression and
metastasis. Adv Biol Regul. 57:75–101. 2015. View Article : Google Scholar
|
|
7
|
Junttila TT, Sundvall M, Lundin M, Lundin
J, Tanner M, Härkönen P, Joensuu H, Isola J and Elenius K:
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of
breast cancer cells. Cancer Res. 65:1384–1393. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naresh A, Long W, Vidal GA, Wimley WC,
Marrero L, Sartor CI, Tovey S, Cooke TG, Bartlett JM and Jones FE:
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein
promoting apoptosis of breast cancer cells. Cancer Res.
66:6412–6420. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang H, Liu M, Yan X, Zhou Y, Wang W,
Wang X, Fu Z, Wang N, Zhang S, Wang Y, et al: miR-193a-3p functions
as a tumor suppressor in lung cancer by down-regulating ERBB4. J
Biol Chem. 290:926–940. 2015. View Article : Google Scholar :
|
|
10
|
Rokavec M, Justenhoven C, Schroth W,
Istrate MA, Haas S, Fischer HP, Vollmert C, Illig T, Hamann U, Ko
YD, et al: A novel polymorphism in the promoter region of ERBB4 is
associated with breast and colorectal cancer risk. Clin Cancer Res.
13:7506–7514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murabito JM, Rosenberg CL, Finger D,
Kreger BE, Levy D, Splansky GL, Antman K and Hwang SJ: A
genome-wide association study of breast and prostate cancer in the
NHLBI's Framingham heart study. BMC Med Genet. 8(8 Suppl 1):
S62007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marjan MN, Hamzeh MT, Rahman E and Sadeq
V: A computational prospect to aspirin side effects: Aspirin and
COX-1 interaction analysis based on non-synonymous SNPs. Comput
Biol Chem. 51:57–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong J, Tong Y, Zhang HM, Wang K, Hu T,
Shan G, Sun J and Guo AY: Genome-wide identification of SNPs in
microRNA genes and the SNP effects on microRNA target binding and
biogenesis. Hum Mutation. 33:254–263. 2012. View Article : Google Scholar
|
|
14
|
Gong J, Liu C, Liu W, Wu Y, Ma Z, Chen H
and Guo AY: An update of miRNASNP database for better SNP selection
by GWAS data, miRNA expression and online tools. Database.
2015:1–8. 2015. View Article : Google Scholar
|
|
15
|
Bao L, Zhou M, Wu L, Lu L, Goldowitz D,
Williams RW and Cui Y: PolymiRTS database: Linking polymorphisms in
microRNA target sites with complex traits. Nucleic Acids Res.
35(Database issue): D51–D54. 2007. View Article : Google Scholar
|
|
16
|
Solé X, Guinó E, Valls J, Iniesta R and
Moreno V: SNPStats: A web tool for the analysis of association
studies. Bioinformatics. 22:1928–1929. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mesrian Tanha H, Mojtabavi Naeini M,
Rahgozar S, Rasa SM and Vallian S: Modified tetra-primer ARMS PCR
as a single-nucleotide polymorphism genotyping tool. Genetic Test
Mol Biomarkers. 19:156–161. 2015. View Article : Google Scholar
|
|
18
|
Su XZ, Wu Y, Sifri CD and Wellems TE:
Reduced extension temperatures required for PCR amplification of
extremely A+T-rich DNA. Nucleic Acids Res. 24:1574–1575. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
'walking' the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HC, Lee JY, Sung H, Choi JY, Park SK,
Lee KM, Kim YJ, Go MJ, Li L, Cho YS, et al: A genome-wide
association study identifies a breast cancer risk variant in ERBB4
at 2q34: Results from the Seoul breast cancer study. Breast Cancer
Res. 14:R562012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ni Y and Siyuan Z: Erbb4 signaling: An
overlooked backup system? Cell Cycle. 14:16232015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang M, Yang Q, Zhang L, Zhou S, Ye W,
Yao Q, Li Z, Huang C, Wen Q and Wang J: miR-302b is a potential
molecular marker of esophageal squamous cell carcinoma and
functions as a tumor suppressor by targeting ErbB4. J Exp Clin
Cancer Res. 33:102014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bandyopadhyay S, Mitra R, Maulik U and
Zhang MQ: Development of the human cancer microRNA network.
Silence. 1:62010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and -5p
suppress the metastasis of human non-small-cell lung cancer by
down-regulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar
|
|
25
|
Zhu Y, Sullivan LL, Nair SS, Williams CC,
Pandey AK, Marrero L, Vadlamudi RK and Jones FE: Coregulation of
estrogen receptor by ERBB4/HER4 establishes a growth-promoting
autocrine signal in breast tumor cells. Cancer Res. 66:7991–7998.
2006. View Article : Google Scholar : PubMed/NCBI
|
